AI-driven CRISPR strategies in breast cancer: Organoid modeling, adaptive editing, and precision delivery
{{output}}
Triple-negative breast cancer (TNBC) is defined by profound heterogeneity, dormant metastatic reservoirs, and rapid therapy resistance. Building on our AI-Driven CRISPR Strategies in Breast Cancer framework, CRISPR-Cas9 is emerging as more than a gene-editing ... ...